menu search

Verifyme, inc. (vrme) q1 2023 earnings call transcript

VerifyMe, Inc. (NASDAQ:VRME ) Q1 2023 Earnings Conference Call May 11, 2023 11:00 AM ET Company Participants Nancy Meyers - SVP, Finance and IR Scott ...

May 11, 2023, 2:30 pm

Allegro microsystems, inc. (algm) q4 2023 earnings call transcript

Start Time: 08:30 January 1, 0000 9:04 AM ET Allegro MicroSystems, Inc. (NASDAQ:ALGM ) Q4 2023 Earnings Conference Call May 11, 2023, 08:30 AM ET Comp...

May 11, 2023, 12:34 pm

Manulife financial corporation (mfc) q1 2023 earnings call transcript

Manulife Financial Corporation (NYSE:MFC ) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Participants Hung Ko - Investor Relations ...

May 11, 2023, 12:30 pm

Neuroone® to report second quarter fiscal year 2023 financial results and provide a corporate update on may 11

EDEN PRAIRIE, Minn., May 11, 2023 (GLOBE NEWSWIRE) -- NeuroOne Medical Technologies Corporation (Nasdaq: NMTC) ("NeuroOne" or the "Company"), a medica...

May 11, 2023, 12:17 pm

Astrotech reports third quarter of fiscal year 2023 financial results

AUSTIN, Texas, May 11, 2023 (GLOBE NEWSWIRE) — Astrotech Corporation (Nasdaq: ASTC) (the “Company” or “Astrotech”) reported its financial re...

May 11, 2023, 12:00 pm

Xwell, inc. to announce first quarter 2023 financial results on monday, may 15

Webcast and Conference Call Scheduled for 5:00 PM ET NEW YORK, May 11, 2023 (GLOBE NEWSWIRE) — XWELL, Inc. (Nasdaq: XWEL) (“XWELL” or the “Com...

May 11, 2023, 12:00 pm

Oncocyte reports first quarter 2023 financial results

Nearing Manufacturing Start Up of First Kitted Product IRVINE, Calif., May 11, 2023 (GLOBE NEWSWIRE) — Oncocyte Corporation (Nasdaq: OCX), a precisi...

May 11, 2023, 12:00 pm

Dyne therapeutics reports first quarter 2023 financial results and business highlights

– On Track to Report Initial Data from ACHIEVE Clinical Trial of DYNE-101 in DM1 and DELIVER Clinical Trial of DYNE-251 in DMD During the Second Hal...

May 11, 2023, 11:30 am

Monte rosa therapeutics announces first quarter 2023 financial results and provides corporate update

On track to present initial data from Phase 1/2 clinical trial of MRT-2359 in MYC-driven solid tumors in the second half of 2023 Cash runway into 2025...

May 11, 2023, 11:30 am

Clearside biomedical announces first quarter 2023 financial results and provides corporate update

– Phase 2b ODYSSEY Trial of CLS-AX in Wet AMD Expected to Open Enrollment in Q2 2023 – – Positive Safety Data, Duration and Biologic Effect of C...

May 11, 2023, 11:05 am

Virios therapeutics announces first quarter 2023 financial results

ATLANTA, May 11, 2023 (GLOBE NEWSWIRE) — Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company foc...

May 11, 2023, 11:05 am

Hookipa pharma reports first quarter 2023 financial results and recent business highlights

HOOKIPA on track to report Phase 2 data on HB-200 for head and neck cancer in combination with pembrolizumab in 2Q 2023 Phase 1 clinical trials initia...

May 11, 2023, 11:01 am

Applied therapeutics reports first quarter 2023 financial results

Demonstrated Long-term Clinical Benefit of Govorestat in ACTION-Galactosemia Kids Trial Strengthened Balance Sheet with $30 Million Private Placement ...

May 11, 2023, 11:00 am

Passage bio reports first quarter 2023 financial results and provides recent business highlights

On track to report interim clinical data for two lead programs, PBGM01 for GM1 gangliosidosis and PBFT02 for frontotemporal dementia (FTD), in 2023 Su...

May 11, 2023, 11:00 am

Optinose reports first quarter 2023 financial results and operational updates

Strong progress towards strategic objectives including acceptance of sNDA for review and prioritization of potential launch of XHANCE as first drug ap...

May 11, 2023, 11:00 am

Tcr² therapeutics reports first quarter 2023 financial results and provides corporate update

CAMBRIDGE, Mass., May 11, 2023 (GLOBE NEWSWIRE) — TCR2 Therapeutics Inc. (Nasdaq: TCRR) (TCR2 or the Company), a clinical-stage cell therapy company...

May 11, 2023, 10:30 am

Fennec pharmaceuticals announces first quarter 2023 financial results and provides business update

~ Strong PEDMARK® Commercial Momentum Building in 2023 with Broad Payor and Medicaid Coverage ~ ~ PEDMARK® Permanent J-Code Effective April 1, 2023 ...

May 11, 2023, 10:01 am

Aveanna healthcare holdings announces first quarter 2023 financial results

Revenue increased 3.5% to $466.4 million, compared to Q1 2022 Gross margin decreased 0.2% to $144.5 million, compared to Q1 2022 Net loss was $32.0 mi...

May 11, 2023, 10:00 am

Viasat sets may 17, 2023 for fourth quarter and fiscal year 2023 financial results conference call and webcast

CARLSBAD, Calif. , May 11, 2023 /PRNewswire/ -- Viasat Inc. (NASDAQ: VSAT), a global communications company, today announced it will release its fourt...

May 11, 2023, 8:00 am

Addex reports q1 2023 financial results and provides corporate update

ADX71149 Phase 2 epilepsy clinical study’s independent interim review committee (“IRC”) recommends continuing study CHF 5.6M ($ 6.1M) of cash an...

May 11, 2023, 5:29 am


Search within

Pages Search Results: